Michael Gross

mgross@bcg-usa.com

 

CV in Adobe

Contact

 

EDUCATION:

Ph.D. Organic Chemistry, Temple University, Philadelphia, PA.
B.Sc. Chemistry, Philadelphia College of Pharmacy and Science, Philadelphia, PA.

EXPERIENCE
CURRENT POSITION
May. 2009- present
 

Senior Consultant, Biologics Consulting Group, Inc., Philadelphia, PA.

   
2007 – May 2009  

Principal Consultant, Chimera Consulting, Philadelphia, PA.

  • Independent consultant specializing in quality, regulatory affairs and development strategy for drugs, biologics, devices and combination products
   
2005 – 2007  

Vice-President, Regulatory Affairs, Cardiome Pharma Corporation, Vancouver, BC.

  • Department head responsible for regulatory submissions, strategy and regulatory agency liaison with therapeutic focus on anti-arrhythmic and other cardiovascular drugs
   
2004 – 2005  

Vice-President, Regulatory Affairs, QLT Incorporated, Vancouver, BC.

  • Department head responsible for regulatory submissions, strategy and regulatory agency liaison with therapeutic focus on ophthalmologic, dermatologic, urologic and oncologic drugs 
   
2001- 2003  

Vice-President World-Wide Compliance, Aventis Behring, King of Prussia, PA.

  • Corporate Compliance department head responsible for regulatory agency liaison for quality systems compliance, internal audit, compliance enhancement and best practices for plasma collection and plasma derived biologics manufacture.
   
1995 -2001  

Director Corporate Regulatory Affairs, Becton Dickinson & Company, Franklin Lakes, NJ.

  • Pharmaceutical Systems Division regulatory affairs department head. responsible for, submissions strategy and regulatory agency liaison for business divisions developing and marketing pharmaceuticals, drug delivery systems and functional pharmaceutical packaging
   
1992 -1995  

Director Regulatory Affairs and Quality Assurance, Becton Dickinson & Company, Franklin Lakes, NJ

  • Transdermal Systems Division regulatory affairs department head responsible for submissions, strategy and regulatory agency liaison and quality systems management for development and registration of drug-device combination products employing novel electrically assisted transdermal drug delivery (iontophoresis) technology
   
1990 -1992  

Principal, Chiros International, Buckingham, PA.

  • Independent consultant specializing in regulatory requirements, submissions and drug development strategies for development and registration of chiral drugs for pharmaceutical clients ranging from large companies to small biotechnology companies
   
1987 – 1990  

Director Regulatory Affairs, Schering-Plough Research Institute, Kenilworth, NJ.

  • Department head responsible for all submissions and regulatory liaison with FDA Divisions of cardio-renal, neuropharmacologic and generic drugs
   
1983 – 1987  

Director Regulatory Affairs/Government Affairs, Triton Biosciences, Shell Oil Company, Alameda, CA.

  • Department head responsible for regulatory submissions, strategy and FDA liaison for recombinant beta-interferon and project manager for development of fludarabine in collaboration with the National Cancer Institute
   
1970-1980  

U.S. Public Health Service, Bethesda, MD.

Chemist, Food and Drug Administration, Bureau of Biologics, Division of Blood and Blood Products, Plasma Derivatives Branch (1970-1980)

  • Reviewer and FDA Inspector for the regulation of plasma protein therapeutics.

Research Chemist, Division of Bacterial Products, Allergenic Products Branch, (1974).

  • Research chemist and reviewer for allergenic extracts and atopic allergens,

Health-Scientist Administrator, National Heart, Lung and Blood Institute, Division of Blood Diseases and Resources (1975 – 1977)

  • Extramural programs manager for basic and clinical research on blood diseases, hemostasis, clotting factors, plasma fractionation, blood products, blood substitutes and biomaterials.

Grants Associate, Division of Research Grants (1974 - 1975)

  • One-year rotational internship in health-science administration, providing broad exposure to the structure, functions and programs of the NIH and sister agencies of the Public Health Service.

 Senior Staff Postdoctoral Fellow, National Institute of Dental Research (1970 – 1974)

  • Intramural scientist, engaged in basic research on fibrin cross-linking, protein chemistry, peptide synthesis, enzyme mechanism, substrate specificity and kinetics.

OTHER RELATED EXPERIENCE

2000-2004 Member, United States Pharmacopoeia, Pharmaceutical Waters Expert Committee
1999-2000

Member, United States Pharmacopoeia, Advisory Committee, Water & Parenterals Sub-committee

1998-present Leader, Parenteral Drug Association, Combination Products Interest Group
1984 Member, Advisory Committee on Biotechnology-California State Assembly
1982-1983 Consultant, United States General Services Administration
1977-1979 FDA Inspector, Security Clearance: Critical Sensitive
1976 PHS Grants Associates Program, Governing Board, Member

HONORS AND AWARDS

1966             American Institute of Chemists Award, Philadelphia College of Pharmacy and Science


PROFESSIONAL AND HONORARY SOCIETIES

2006-2007 Chair, Regulatory Affairs Professionals Society, Southern BC Chapter
1991-1993 Member, Pennsylvania Biotechnology Association, Board of Directors
1989-1990 Member, Pharmaceutical Manufacturers Association, Committee on Racemic Mixtures
1983-1987 Founder and Member, Industrial Biotechnology Association, FDA Affairs Committee

ADDITIONAL TRAINING

  • RAPS-RCAB, Regulatory Affairs Certified (RAC)

Page Updated: July 23, 2010

2010 © Biologics Consulting Group, Inc. - All Rights Reserved